0001415889-22-001736.txt : 20220223 0001415889-22-001736.hdr.sgml : 20220223 20220223201204 ACCESSION NUMBER: 0001415889-22-001736 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Funck, Jr. Robert E. CENTRAL INDEX KEY: 0001565892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 22665884 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-378, AP6D-2 CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 FORMER NAME: FORMER CONFORMED NAME: Funck Robert E DATE OF NAME CHANGE: 20130103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02232022_050248.xml X0306 4 2022-02-18 0000001800 ABBOTT LABORATORIES ABT 0001565892 Funck, Jr. Robert E. 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT Common shares without par value 2022-02-18 4 A 0 28682 0 A 217332 D Common shares without par value 10000 I By Trust Common shares without par value 10000 I By Trust Common shares without par value 18085 I Profit Sharing Trust Common shares without par value 500 I By Daughter Option (right to buy) 117.58 2022-02-18 4 A 0 133670 0 A 2023-02-18 2032-02-17 Common Shares 133670 133670 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust. Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022. The reporting person disclaims beneficial ownership of all securities held by his daughter. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,556 on February 18, 2023, 44,557 on February 18, 2024, and 44,557 on February 18, 2025. /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact 2022-02-23